Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exemestane for breast cancer prevention
NCT00083174Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Dec 2004
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of exemestane in breast cancer, sponsored by Canadian Cancer Trials Group. Started Dec 2004; status: completed.
02
Drugs
exemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00083174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00083174.